Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Godaddy Inc (GDDY) vs Twist Bioscience Corp (TWST) Price & Performance

Godaddy IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Godaddy Inc vs Twist Bioscience Corp — how do they compare? Godaddy Inc trades at $92.13 (market cap $11.49B), while Twist Bioscience Corp trades at $124.14 (market cap $7.72B). The key difference: Godaddy Inc is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Godaddy Inc nearer its low. Which is the better fit depends on your goals.

GDDYTWST
Market Cap
$11.49B$7.72B
Sector
TechnologyHealth
52-Week High
$148.88$124.88
52-Week Low
$75.07$24.16
Enterprise Value
$14.18B$7.65B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Godaddy Inc

GoDaddy (GDDY) trades at $90.78, down 0.78% on the day, with a bearish technical signal and mixed sentiment due to ongoing securities investigations. Fundamentally, the company shows strength with consistent earnings beats, revenue growth to $4.95B in 2025, and robust profitability margins. The stock trades at a P/E of 13.48, below the sector average, while analyst consensus targets $112.13, implying significant upside.

The outlook is cautiously optimistic given solid fundamentals and analyst support, but near-term volatility is likely from legal overhangs and technical resistance. Key risks include potential litigation outcomes and competitive pressures in web services. Upside hinges on continued execution and clearing regulatory concerns.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $123.76, down 0.9% on the day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, with 2025 revenue at $376.57 million, though the company remains unprofitable with a net income margin of -31.66%. Recent news highlights an upsized $300 million public offering and an analyst upgrade, contributing to positive sentiment.

The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, negative cash flow, and high valuation ratios pose significant risks. Investors should weigh the growth trajectory against the path to profitability and cash burn concerns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Godaddy Inc

GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.

Read more on GDDY

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST